𝔖 Bobbio Scriptorium
✦   LIBER   ✦

miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue

✍ Scribed by Latha Ramdas; Uma Giri; Cheryl L. Ashorn; Kevin R. Coombes; Adel El-Naggar; K. Kian Ang; Michael D. Story


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
584 KB
Volume
31
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background.

The expression of miRNA in head and neck squamous cell carcinomas (HNSCCs) that had been classified as high risk by surgical pathologic features and validated by trial outcome for disease recurrence was determined and compared with matched adjacent normal tissues.

Methods.

miRNA and corresponding gene expression were determined using miRNA bioarrays and gene expression arrays.

Results.

Twenty miRNAs were determined to be differentially regulated in the HNSCC samples when compared with their normal tissue counterparts. Quantitative reverse transcriptase‐polymerase chain reaction confirmed differential regulation of miRNA expression, and gene expression analysis on these same‐paired samples confirmed the loss of putative mRNA targets including genes such as adenomatous polyposis coli, programmed cell death protein 4, and TGF beta receptor 3 in the tumor samples.

Conclusions.

These data suggest a role for the upregulation of specific miRNAs in high‐risk HNSCC. Furthermore, upregulation of these miRNAs may be responsible for the elimination of mRNAs that lead to the growth and progression of HNSCC. Β© 2009 Wiley Periodicals, Inc. Head Neck, 2009


πŸ“œ SIMILAR VOLUMES


Gene expression profiling in head and ne
✍ Benjamin Lallemant; Alexandre Evrard; Guillaume Chambon; Omar Sabra; Sophie Kach πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 108 KB πŸ‘ 2 views

## Abstract ## __Background.__ To date, more than 60 gene expression profiling (GEP) studies have been published in the field of head and neck squamous cell carcinoma (HNSCC) with variable objectives, methods, and results. ## __Methods.__ The purpose of this study was to present a state‐of‐the‐a

Expression profiles of angiogenic growth
✍ Simon Ninck; Christoph Reisser; Gerhard Dyckhoff; Burkhard Helmke; Harald Bauer; πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 848 KB

## Abstract Inhibition of angiogenesis by blocking angiogenic cytokines or their pathways has become a major target in experimental cancer therapies. This therapeutical approach requires a profound knowledge of growth factor profiles that contribute to tumor growth and progression. The respective k

Frequent expression of Niban in head and
✍ Shin Ito; Hiroaki Fujii; Toshiharu Matsumoto; Masaaki Abe; Katsuhisa Ikeda; Okio πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 305 KB πŸ‘ 2 views

## Abstract ## Background Niban was initially identified in the Eker rat, a model of renal carcinogenesis. We examined Niban expression in head and neck squamous cell carcinoma (HNSCC) and head and neck dysplastic lesions. ## Methods Using a polyclonal rabbit anti‐human Niban antibody, 43 cases

Head and neck squamous cell carcinoma in
✍ de Carvalho, Marcos Brasilino; Sobrinho, Josias de Andrade; Rapoport, AbrΓ£o; Fav πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 103 KB πŸ‘ 2 views

## Background: Squamous cell carcinoma (scc) of the head and neck region is rare in young patients and even less frequent in children 15 years or younger children. the patients reported in the literature are isolated cases and their management is always difficult because there is no large experienc

MicroRNA expression profiles of head and
✍ Yuemeng Dai; Cheng-hui Xie; John P. Neis; Chun-Yang Fan; Emre Vural; Paul M. Spr πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 220 KB πŸ‘ 2 views

## Abstract ## Background The purpose of this study was to investigate the potential role of variable microRNA (miRNA) expression in the development of multidrug resistance (MDR) in head and neck cancer. ## Methods Head and neck squamous cell carcinoma cell lines UMSCC‐1 and SQ20B were treated w